Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $2.5M | ﹤0.01% |
104,838
+63,935
| +156% | +$1.6M |
|
2652
Nuveen Credit Strategies Income Fund
JQC
$720M
| $2.49M | ﹤0.01% |
492,947
+61,898
| +14% | +$314K |
|
|
CHY
2653
Calamos Convertible and High Income Fund
CHY
$1.09B
| $2.49M | ﹤0.01% |
222,945
+4,121
| +2% | +$46.4K |
|
|
ADAM
2654
Adamas Trust
ADAM
$915M
| $2.48M | ﹤0.01% |
291,919
-104,042
| -26% | -$984K |
|
|
DQ
2655
Daqo New Energy
DQ
$1.01B
| $2.48M | ﹤0.01% |
82,209
+24,722
| +43% | +$881K |
|
2656
New Mountain Finance
NMFC
$738M
| $2.46M | ﹤0.01% |
189,530
+24,544
| +15% | +$313K |
|
2657
Marcus Corp
MCS
$926M
| $2.46M | ﹤0.01% |
158,546
-7,223
| -4% | -$111K |
|
2658
Bath & Body Works
BBWI
$3.72B
| $2.45M | ﹤0.01% |
72,632
-391,046
| -84% | -$14.2M |
|
2659
iShares MSCI Chile ETF
ECH
$1.03B
| $2.45M | ﹤0.01% |
93,478
+18,476
| +25% | +$533K |
|
|
KREF
2660
KKR Real Estate Finance Trust
KREF
$499M
| $2.45M | ﹤0.01% |
205,118
-24,376
| -11% | -$300K |
|
2661
RPC Inc
RES
$1.39B
| $2.45M | ﹤0.01% |
273,628
-23,920
| -8% | -$200K |
|
2662
Atara Biotherapeutics
ATRA
$77.3M
| $2.44M | ﹤0.01% |
66,061
+20,116
| +44% | +$895K |
|
|
ETG
2663
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.87B
| $2.44M | ﹤0.01% |
156,050
-76,933
| -33% | -$1.27M |
|
|
ESMT
2664
DELISTED
EngageSmart, Inc.
ESMT
| $2.44M | ﹤0.01% |
135,552
-142,141
| -51% | -$2.53M |
|
|
NML
2665
Neuberger Energy Infrastructure and Income Fund Inc
NML
$606M
| $2.44M | ﹤0.01% |
353,764
+13,149
| +4% | +$91.9K |
|
|
IMVP
2666
Invesco India ETF
IMVP
$108M
| $2.44M | ﹤0.01% |
103,801
+70,019
| +207% | +$1.64M |
|
2667
Establishment Labs
ESTA
$2.27B
| $2.43M | ﹤0.01% |
49,518
-5,015
| -9% | -$300K |
|
2668
Baytex Energy
BTE
$2.99B
| $2.42M | ﹤0.01% |
548,619
-99,081
| -15% | -$389K |
|
2669
Valens Semiconductor
VLN
$212M
| $2.4M | ﹤0.01% |
903,622
-272,866
| -23% | -$686K |
|
2670
Array Technologies
ARRY
$812M
| $2.4M | ﹤0.01% |
107,956
+60,991
| +130% | +$1.32M |
|
2671
James River Group Holdings
JRVR
$201M
| $2.39M | ﹤0.01% |
155,675
-12,233
| -7% | -$199K |
|
2672
iShares Mortgage Real Estate ETF
REM
$547M
| $2.38M | ﹤0.01% |
106,663
+16,992
| +19% | +$404K |
|
|
FFC
2673
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$781M
| $2.38M | ﹤0.01% |
183,570
-74,224
| -29% | -$1M |
|
2674
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$801M
| $2.38M | ﹤0.01% |
66,877
-33,037
| -33% | -$1.18M |
|
2675
Amylyx Pharmaceuticals
AMLX
$2.53B
| $2.38M | ﹤0.01% |
129,918
-254
| -0.2% | -$5.37K |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.